Literature DB >> 34269964

Latent Tri-lineage Potential of Human Menstrual Blood-Derived Mesenchymal Stromal Cells Revealed by Specific In Vitro Culture Conditions.

Diana Quintero-Espinosa1, Viviana Soto-Mercado1, Catherine Quintero-Quinchia1, Carlos Velez-Pardo1, Miguel Mendivil-Perez1, Marlene Jimenez-Del-Rio2.   

Abstract

Human menstrual blood-derived mesenchymal stromal cells (MenSCs) have become not only an important source of stromal cells for cell therapy but also a cellular source for neurologic disorders in vitro modeling. By using culture protocols originally developed in our laboratory, we show that MenSCs can be converted into floating neurospheres (NSs) using the Fast-N-Spheres medium for 24-72 h and can be transdifferentiated into functional dopaminergic-like (DALNs, ~ 26% TH + /DAT + flow cytometry) and cholinergic-like neurons (ChLNs, ~ 46% ChAT + /VAChT flow cytometry) which responded to dopamine- and acetylcholine-triggered neuronal Ca2+ inward stimuli when cultured with the NeuroForsk and the Cholinergic-N-Run medium, respectively in a timely fashion (i.e., 4-7 days). Here, we also report a direct transdifferentiation method to induce MenSCs into functional astrocyte-like cells (ALCs) by incubation of MenSCs in commercial Gibco® Astrocyte medium in 7 days. The MSC-derived ALCs (~ 59% GFAP + /S100β +) were found to respond to glutamate-induced Ca2+ inward stimuli. Altogether, these results show that MenSCs are a reliable source to obtain functional neurogenic cells to further investigate the neurobiology of neurologic disorders.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Astrocyte; Calcium; Cholinergic; Dopaminergic; Menstrual blood; Neurogenic; Stromal

Mesh:

Year:  2021        PMID: 34269964     DOI: 10.1007/s12035-021-02442-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  46 in total

1.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

2.  Comparative capability of menstrual blood versus bone marrow derived stem cells in neural differentiation.

Authors:  Fereshteh Azedi; Somaieh Kazemnejad; Amir Hassan Zarnani; Masoud Soleimani; Amir Shojaei; Shaghayegh Arasteh
Journal:  Mol Biol Rep       Date:  2016-12-15       Impact factor: 2.316

3.  Differentiation potential of menstrual blood- versus bone marrow-stem cells into glial-like cells.

Authors:  Fereshteh Azedi; Somaieh Kazemnejad; Amir Hassan Zarnani; Gila Behzadi; Mohammad Vasei; Manijeh Khanmohammadi; Sayeh Khanjani; Haleh Edalatkhah; Niknam Lakpour
Journal:  Cell Biol Int       Date:  2014-02-13       Impact factor: 3.612

Review 4.  Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.

Authors:  Princy Choudhary; Ayushi Gupta; Sangeeta Singh
Journal:  J Mol Neurosci       Date:  2020-10-13       Impact factor: 3.444

5.  Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.

Authors:  S Viswanathan; Y Shi; J Galipeau; M Krampera; K Leblanc; I Martin; J Nolta; D G Phinney; L Sensebe
Journal:  Cytotherapy       Date:  2019-09-13       Impact factor: 5.414

Review 6.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

Review 7.  Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.

Authors:  Ali Shariati; Reza Nemati; Yasin Sadeghipour; Yoda Yaghoubi; Reza Baghbani; Kamran Javidi; Majid Zamani; Ali Hassanzadeh
Journal:  Eur J Cell Biol       Date:  2020-06-26       Impact factor: 4.492

8.  Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice.

Authors:  Yongjia Zhao; Xin Chen; Yichen Wu; Yanling Wang; Yifei Li; Charlie Xiang
Journal:  Front Mol Neurosci       Date:  2018-04-24       Impact factor: 5.639

Review 9.  Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases.

Authors:  Lijun Chen; Jingjing Qu; Tianli Cheng; Xin Chen; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2019-12-21       Impact factor: 6.832

View more
  2 in total

1.  Polycationic peptide R7-G-Aβ25-35 selectively induces cell death in leukemia Jurkat T cells through speedy mitochondrial depolarization, and CASPASE-3 -independent mechanism.

Authors:  Miguel Mendivil-Perez; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Biochem Biophys Rep       Date:  2022-06-18

2.  (-)-Epigallocatechin-3-Gallate Diminishes Intra-and Extracellular Amyloid-Induced Cytotoxic Effects on Cholinergic-like Neurons from Familial Alzheimer's Disease PSEN1 E280A.

Authors:  Viviana Soto-Mercado; Miguel Mendivil-Perez; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio
Journal:  Biomolecules       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.